drug

neuropsychological testing

Neuropsychological Testing
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by National Institute of Mental Health (NIMH)
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

3
Effects of Modafinil on Brain Function in Patients With Schizophrenia
NCT00057707Phase 1Completed
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
NCT00548327Phase 2Terminated
5HT3 Antagonism and Auditory Gating in Schizophrenia
NCT00018850—Completed

KOLs & investigators

1
Jose A Apud, M.D.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
National Institute of Mental Health (NIMH)
company
trial
Effects of Modafinil on Brain Function in Patients With Schizophrenia
PHASE1
trial
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
PHASE2
trial
5HT3 Antagonism and Auditory Gating in Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Cognition Disorders
indication
Psychotic Disorders
indication
KOL
Jose A Apud, M.D.
KOL score —
person